These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28708400

  • 21. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
    Doki K, Apáti S, Sakata T, Homma M.
    Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
    [Abstract] [Full Text] [Related]

  • 22. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M, Bilos A, van den Heuvel JJMW, Rijpma SR, Hurkmans EGE, Sauerwein RW, Russel FGM, Koenderink JB.
    Malar J; 2017 Oct 23; 16(1):422. PubMed ID: 29061131
    [Abstract] [Full Text] [Related]

  • 23. Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).
    Saad AAA, Zhang F, Mohammed EAH, Wu X.
    Biol Pharm Bull; 2022 Oct 23; 45(4):382-393. PubMed ID: 35370262
    [Abstract] [Full Text] [Related]

  • 24. Multiple organic cation transporters contribute to the renal transport of sulpiride.
    Li L, Weng Y, Wang W, Bai M, Lei H, Zhou H, Jiang H.
    Biopharm Drug Dispos; 2017 Dec 23; 38(9):526-534. PubMed ID: 28926871
    [Abstract] [Full Text] [Related]

  • 25. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
    Meyer zu Schwabedissen HE, Verstuyft C, Kroemer HK, Becquemont L, Kim RB.
    Am J Physiol Renal Physiol; 2010 Apr 23; 298(4):F997-F1005. PubMed ID: 20053795
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2-MATE1).
    Ma Y, Wang X, Gou X, Wu X.
    Biopharm Drug Dispos; 2024 Feb 23; 45(1):43-57. PubMed ID: 38305087
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat.
    Lepist EI, Zhang X, Hao J, Huang J, Kosaka A, Birkus G, Murray BP, Bannister R, Cihlar T, Huang Y, Ray AS.
    Kidney Int; 2014 Aug 23; 86(2):350-7. PubMed ID: 24646860
    [Abstract] [Full Text] [Related]

  • 31. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
    Nishizawa K, Yoda N, Morokado F, Komori H, Nakanishi T, Tamai I.
    PLoS One; 2019 Aug 23; 14(4):e0214862. PubMed ID: 30951542
    [Abstract] [Full Text] [Related]

  • 32. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
    Strobel J, Müller F, Zolk O, Endreß B, König J, Fromm MF, Maas R.
    Amino Acids; 2013 Oct 23; 45(4):989-1002. PubMed ID: 23864433
    [Abstract] [Full Text] [Related]

  • 33. Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families.
    Chen J, Brockmöller J, Seitz T, König J, Chen X, Tzvetkov MV.
    Biol Chem; 2017 Feb 01; 398(2):237-249. PubMed ID: 27676604
    [Abstract] [Full Text] [Related]

  • 34. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
    Omote S, Matsuoka N, Arakawa H, Nakanishi T, Tamai I.
    Sci Rep; 2018 Jun 18; 8(1):9237. PubMed ID: 29915248
    [Abstract] [Full Text] [Related]

  • 35. [Establishment of MDCK cell models expressing human MATE1 or co-expressing with human OCT1 or OCT2].
    Lei HM, Sun SY, Li LP, Tu MJ, Zhou H, Zeng S, Jiang HD.
    Yao Xue Xue Bao; 2015 Jul 18; 50(7):842-7. PubMed ID: 26552145
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.